‘Opioids’ Is Missing From The US FDA’s Overdose Prevention Framework Title On Purpose

 
• By Derrick Gingery

Unlike prior plans, the FDA’s new substance abuse framework is intended to deal with stimulant and benzodiazepine use disorders, in addition to opioid abuse.

divergent path
The Overdose Prevention Framework diverges from previous substance abuse plans, which were focused on opioids. • Source: Shutterstock

More from US FDA

More from Agency Leadership